Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

NCT00324805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1501

Enrollment

NIH

Sponsor class

Conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Stage IIA Lung Non-Small Cell Carcinoma AJCC v7
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
Stage IIIA Lung Non-Small Cell Cancer AJCC v7

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Cisplatin
DRUG: Docetaxel
DRUG: Gemcitabine Hydrochloride
OTHER: Laboratory Biomarker Analysis
DRUG: Pemetrexed Disodium
OTHER: Questionnaire Administration
DRUG: Vinorelbine Tartrate

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]